WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com, a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, reported today that it has engaged IRG, LLC (IRG), a prominent, full service corporate communications firm, to serve as its investor relations agency.
